Tag: food and drug administration
Democratic Senators Propose Law to Address Unprecedented Drug Shortages
by Melly Alazraki on Feb.08, 2011, under Towing
Health care providers have been reporting unprecedented shortages of prescription drugs, including vital medications such as chemotherapies and antibiotics. Under current law, the FDA has no power to act, so two senators have introduced a bill to help government get a handle on the problem.
Continue reading Democratic Senators Propose Law to Address Unprecedented Drug Shortages
Democratic Senators Propose Law to Address Unprecedented Drug Shortages originally appeared on DailyFinance on Tue, 08 Feb 2011 13:45:00.
Filed Under: Health Care
FDA Rejects Orexigen’s New Diet Drug Over Heart Concerns
by Melly Alazraki on Feb.01, 2011, under Towing
In a surprise move Tuesday, the FDA rejected Orexigen’s proposed new diet drug Contrave, saying the company needed to run another study of its cardiovascular risks. With this rejection, all three of a slate of similar diet drugs from competing pharmaceuticals have been turned back by the agency.
Continue reading FDA Rejects Orexigen’s New Diet Drug Over Heart Concerns
FDA Rejects Orexigen’s New Diet Drug Over Heart Concerns originally appeared on DailyFinance on Tue, 01 Feb 2011 11:17:00.
Filed Under: Company News, Health Care, Stocks in the News
Caffeinated Alcoholic Beverages Go Green: Recycler Turns Them Into Ethanol
by Danny King on Jan.06, 2011, under Towing
Could caffeinated alcoholic drinks, which the FDA deemed unsafe for human consumption in November, turn out to be good for cars? A Virginia-based ethanol recycler, MXI Environmental Services, is turning those soon-to-be-banned beverages into fuel.
Continue reading Caffeinated Alcoholic Beverages Go Green: Recycler Turns Them Into Ethanol
Caffeinated Alcoholic Beverages Go Green: Recycler Turns Them Into Ethanol originally appeared on DailyFinance on Thu, 06 Jan 2011 18:30:00.
FDA Panel Backs Orexigen’s Diet Pill
by Melly Alazraki on Dec.07, 2010, under Towing
After the U.S. Food and Drug Administration rejected two other weight-loss pills earlier this year, an advisory panel has recommended the approval of Orexigen Therapeutics’s Contrave. If the FDA follows the recommendation, Contrave could become the first diet drug to win approval in a decade.
Continue reading FDA Panel Backs Orexigen’s Diet Pill
FDA Panel Backs Orexigen’s Diet Pill originally appeared on DailyFinance on Tue, 07 Dec 2010 20:30:00.
Filed Under: Company News, Health Care, Stocks in the News
Allergan Seeks Broader FDA Approval for Weight-Loss Implant
by Melly Alazraki on Dec.01, 2010, under Towing
Allergan’s Lap-Band, a device implanted in the stomach to limit the amount of food that can be ingested, is already on the market to help the very obese lose weight. But now the company hopes to win approval for less obese patients to use the band.
Continue reading Allergan Seeks Broader FDA Approval for Weight-Loss Implant
Allergan Seeks Broader FDA Approval for Weight-Loss Implant originally appeared on DailyFinance on Wed, 01 Dec 2010 20:45:00.
Filed Under: Health Care






